Autoimmune Thyroid Disease and Keratoconus: Is There an Association?

Hussam H Alhawari, Yousef S Khader, Hussein H Alhawari, Amal F Alomari, Hiba N Abbasi, Muhannd S El-Faouri, Muawyah D Al Bdour, Hussam H Alhawari, Yousef S Khader, Hussein H Alhawari, Amal F Alomari, Hiba N Abbasi, Muhannd S El-Faouri, Muawyah D Al Bdour

Abstract

Purpose: The association between autoimmune diseases and keratoconus (KC) has been proposed based on previous retrospective studies and case reports. The aim of our study is to investigate whether KC is associated with autoimmune thyroid disease. Methods. A comparative study was conducted on 131 adult subjects from September 2015 to May 2017 at Jordan University Hospital, Amman, Jordan. Subjects were classified into 2 groups: subjects with autoimmune thyroid disease, including Graves' disease and Hashimoto's thyroiditis (n = 68), and a healthy group for comparison (n = 63). Subjects with any other conditions known to be associated with KC were excluded. The diagnosis of KC was based on clinical and corneal topographic findings utilizing the Oculus-Pentacam machine. In addition, TSH and total T4 levels as well as thyroid peroxidase antibodies were measured in all study participants. Antithyroglobulin antibodies, thyroid stimulating immunoglobulin, thyroid ultrasound, and thyroid uptake and scan were also selectively performed in some participants.

Results: This study included a total of 131 participants (101 females and 30 males), including patients and controls. In the multivariate analysis, autoimmune disease was not significantly associated with keratoconus (OR = 1.1; 95% confidence interval: 0.3, 3.8; p value = 0.353) after adjusting for age and gender.

Conclusion: This study did not show a statistically significant association between autoimmune thyroid disease and KC.

References

    1. Rabinowitz Y. S. Keratoconus. Survey of Ophthalmology. 1998;42(4):297–319. doi: 10.1016/S0039-6257(97)00119-7.
    1. Abu Ameerh M. A., Al Refai R. M., Al Bdour M. D. Keratoconus patients at Jordan University Hospital: a descriptive study. Clinical Ophthalmology. 2012;6:1895–1899. doi: 10.2147/OPTH.S38287.
    1. McMonnies C. W. Inflammation and keratoconus. Optometry and Vision Science. 2015;92(2):e35–e41. doi: 10.1097/OPX.0000000000000455.
    1. Olivares Jiménez J. L., Guerrero Jurado J. C., Bermudez Rodriguez F. J., Serrano Laborda D. Keratoconus: age of onset and natural history. Optometry and Vision Science. 1997;74(3):147–151.
    1. Assiri A. A., Yousuf B. I., Quantock A. J., Murphy P. J. Incidence and severity of keratoconus in Asir province, Saudi Arabia. The British Journal of Ophthalmology. 2005;89(11):1403–1406. doi: 10.1136/bjo.2005.074955.
    1. Ziaei H., Jafarinasab M. R., Javadi M. A., et al. Epidemiology of keratoconus in an Iranian population. Cornea. 2012;31(9):1044–1047. doi: 10.1097/ICO.0b013e31823f8d3c.
    1. Waked N., Fayad A. M., Fadlallah A., El Rami H. Keratoconus screening in a Lebanese students’ population. Journal Français d'Ophtalmologie. 2012;35(1):23–29. doi: 10.1016/j.jfo.2011.03.016.
    1. Millodot M., Shneor E., Albou S., Atlani E., Gordon-Shaag A. Prevalence and associated factors of keratoconus in Jerusalem: a cross-sectional study. Ophthalmic Epidemiology. 2011;18(2):91–97. doi: 10.3109/09286586.2011.560747.
    1. Shehadeh M. M., Diakonis V. F., Jalil S. A., Younis R., Qadoumi J., Al-Labadi L. Prevalence of keratoconus among a Palestinian tertiary student population. The Open Ophthalmology Journal. 2015;9(1):172–176. doi: 10.2174/1874364101509010172.
    1. Shneor E., Millodot M., Gordon-Shaag A., et al. Prevalence of keratoconus among young Arab students in Israel. International Journal of Keratoconus and Ectatic Corneal Diseases. 2014;3(1):9–14.
    1. Pearson A. R., Soneji B., Sarvananthan N., Sandford-Smith J. H. Does ethnic origin influence the incidence or severity of keratoconus? Eye. 2000;14(4):625–628. doi: 10.1038/eye.2000.154.
    1. Kennedy R. H., Bourne W. M., Dyer J. A. A 48-year clinical and epidemiologic study of keratoconus. American Journal of Ophthalmology. 1986;101(3):267–273. doi: 10.1016/0002-9394(86)90817-2.
    1. Gokhale N. S. Epidemiology of keratoconus. Indian Journal of Ophthalmology. 2013;61(8):382–383. doi: 10.4103/0301-4738.116054.
    1. Naderan M., Rajabi M. T., Zarrinbakhsh P., Bakhshi A. Effect of allergic diseases on keratoconus severity. Ocular Immunology and Inflammation. 2016;25(3):418–423. doi: 10.3109/09273948.2016.1145697.
    1. Kumar S. Vernal keratoconjunctivitis: a major review. Acta Ophthalmologica. 2009;87(2):133–147. doi: 10.1111/j.1755-3768.2008.01347.x.
    1. Sugar J., Macsai M. S. What causes keratoconus? Cornea. 2012;31(6):716–719. doi: 10.1097/ICO.0b013e31823f8c72.
    1. Galvis V., Sherwin T., Tello A., Merayo J., Barrera R., Acera A. Keratoconus: an inflammatory disorder? Eye. 2015;29(7):843–859. doi: 10.1038/eye.2015.63.
    1. Smiddy W. E., Hamburg T. R., Kracher G. P., Stark W. J. Keratoconus. Contact lens or keratoplasty? Ophthalmology. 1988;95(4):487–492. doi: 10.1016/S0161-6420(88)33161-1.
    1. Raiskup-Wolf F., Hoyer A., Spoerl E., Pillunat L. E. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. Journal of Cataract and Refractive Surgery. 2008;34(5):796–801. doi: 10.1016/j.jcrs.2007.12.039.
    1. Nemet A. Y., Vinker S., Bahar I., Kaiserman I. The association of keratoconus with immune disorders. Cornea. 2010;29(11):1261–1264. doi: 10.1097/ICO.0b013e3181cb410b.
    1. Gatzioufas Z., Panos G. D., Brugnolli E., Hafezi F. Corneal topographical and biomechanical variations associated with hypothyroidism. Journal of Refractive Surgery. 2014;30(2):78–79. doi: 10.3928/1081597X-20140120-01.
    1. Gatzioufas Z., Thanos S. Acute keratoconus induced by hypothyroxinemia during pregnancy. Journal of Endocrinological Investigation. 2008;31(3):262–266. doi: 10.1007/BF03345600.
    1. Koçak Altintas A. G., Gül U., Duman S. Bilateral keratoconus associated with Hashimoto's disease, alopecia areata and atopic keratoconjunctivitis. European Journal of Ophthalmology. 1999;9(2):130–133. doi: 10.1177/112067219900900210.
    1. AlHawari H. H., Al Bdour M. D. Vernal keratoconjunctivitis and severe keratoconus associated with autoimmune polyglandular syndrome type II (APS-2): a case report. Jordan Medical Journal. 2016;50(3):157–159. doi: 10.12816/0033485.
    1. Thanos S., Oellers P., Meyer Zu Hörste M., et al. Role of thyroxine in the development of keratoconus. Cornea. 2016;35(10):1338–1346. doi: 10.1097/ICO.0000000000000988.
    1. Levy J., Sobel R., Marcus M., Lifshitz T. Thyroid ophthalmopathy. Minerva Endocrinologica. 2005;30(4):247–265.
    1. Barsouk A., Peele K. A., Kiljanski J., et al. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction. Journal of Endocrinological Investigation. 1996;19(6):334–341. doi: 10.1007/BF03344966.
    1. Fairweather D., Frisancho-Kiss S., Rose N. R. Sex differences in autoimmune disease from a pathological perspective. The American Journal of Pathology. 2008;173(3):600–609. doi: 10.2353/ajpath.2008.071008.
    1. Chaudhary V., Bano S. Thyroid ultrasound. Indian Journal of Endocrinology and Metabolism. 2013;17(2):219–227. doi: 10.4103/2230-8210.109667.
    1. Rahi A., Davies P., Ruben M., Lobascher D., Menon J. Keratoconus and coexisting atopic disease. The British Journal of Ophthalmology. 1977;61(12):761–764. doi: 10.1136/bjo.61.12.761.
    1. Totan Y., Hepşen I. F., Cekiç O., Gündüz A., Aydin E. Incidence of keratoconus in subjects with vernal keratoconjunctivitis: a videokeratographic study. Ophthalmology. 2001;108(4):824–827. doi: 10.1016/S0161-6420(00)00664-3.
    1. Ozcan A. A., Ersoz T. R. Severe acute corneal hydrops in a patient with Down syndrome and persistent eye rubbing. Annals of Ophthalmology. 2007;39(2):158–160. doi: 10.1007/s12009-007-0009-6.
    1. Macsai M., Maguen E., Nucci P. Keratoconus and Turner’s syndrome. Cornea. 1997;16(5):534–536.
    1. Sever J. L., South M. A., Shaver K. A. Delayed manifestations of congenital rubella. Reviews of Infectious Diseases. 1985;7(Supplement_1):S164–S169. doi: 10.1093/clinids/7.Supplement_1.S164.
    1. Tunbridge W. M. G., Evered D. C., Hall R., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology. 1977;7(6):481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x.
    1. Kahán I. L., Varsányi-Nagy M., Tóth M., Nádrai A. The possible role of tear fluid thyroxine in keratoconus development. Experimental Eye Research. 1990;50(4):339–343. doi: 10.1016/0014-4835(90)90134-G.
    1. Stachon T., Stachon A., Hartmann U., Seitz B., Langenbucher A., Szentmáry N. Urea, uric acid, prolactin and fT4 concentrations in aqueous humor of keratoconus patients. Current Eye Research. 2017;42(6):842–846. doi: 10.1080/02713683.2016.1256413.
    1. Masterson E., Edelhauser H. F., Van Horn D. L. The role of thyroid hormone in the development of the chick corneal endothelium and epithelium. Investigative Ophthalmology & Visual Science. 1977;16(2):105–115.
    1. Carlson B. M. Human Embryology and Developmental Biology. 5th. Philadelphia: Saunders Elsevier; 2014.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する